Table 2 Clinical characteristics of the low/high BPS patients with glioma from Hui Zhou central people’s Hospital.
From: Mutational accumulation drives pathway dysregulation to predict glioma patient survival
Factor | Overall (n = 45) | low (n = 26) | high (n = 19) | p value* |
|---|---|---|---|---|
Age (mean) | 59.38 | 58.65 | 60.37 | 0.592 |
Gender (%) | ||||
Female | 16 (35.6%) | 10 (38.5%) | 6 (31.6%) | 0.872 |
Male | 29 (64.4%) | 16 (61.5%) | 13 (68.4%) | |
Subtype (%) | ||||
LGG | 27 (60%) | 20 (76.9%) | 7 (36.8%) | 0.016 |
HGG | 18 (40%) | 6 (23.1%) | 12 (63.2%) | |
IDH1 (%) | ||||
No | 21 (46.7%) | 8 (30.8%) | 13 (68.4%) | 0.028 |
Yes | 24 (53.3%) | 18 (69.2%) | 6 (31.6%) | |
